Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trial.
[This corrects the article DOI: 10.1093/noajnl/vdab153.].
Song, Andrew J; Ding, Keyue; Alnahhas, Iyad; Laperriere, Normand J; Perry, James; Mason, Warren P; Winch, Chad; O'Callaghan, Chris J; Menten, Johan J; Brandes, Alba A; Phillips, Claire; Fay, Michael F; Nishikawa, Ryo; Osoba, David; Cairncross, J Gregory; Roa, Wilson; Wick, Wolfgang; and Shi, Wenyin, "Corrigendum to: Impact of lymphopenia on survival for elderly patients with glioblastoma: A secondary analysis of the CCTG CE.6 (EORTC 26062-22061, TROG 08.02) randomized clinical trial." (2022). Department of Radiation Oncology Faculty Papers. Paper 168.
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License
This article is the author's final published version in Neuro-Oncology Advances, Volume 4, Issue 1, January 2022, Article number vdac011.
The published version is available at https://doi.org/10.1093/noajnl/vdac011.
Copyright © The Author(s) 2022. Published by Oxford University Press, the Society for Neuro-Oncology and the European Association of Neuro-Oncology.This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact email@example.com